Related Experiment Videos
Absolute lymphocyte count as a predictive factor for response to monoclonal anti-CD20 antibody therapy
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Imaging patterns and diagnostic challenges in metastatic invasive lobular carcinoma.
European journal of radiology·2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Impact of adjuvant radiotherapy and chemotherapy on thymoma.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
IVIG-associated anterior uveitis resolving after switch to subcutaneous immunoglobulin.
Immunotherapy advances·2026